首页 > 最新文献

Australian family physician最新文献

英文 中文
Bipolar disorder. 双相情感障碍。
Q3 Medicine Pub Date : 2021-12-17 DOI: 10.1353/book.49280
P. Mitchell
BACKGROUNDBipolar disorder affects about 1% of Australians and impacts severely on relationships, careers and general functional capacity. General practitioners are central in the management of patients with bipolar disorder.OBJECTIVETo update clinicians on the recognition, diagnosis and management of bipolar disorder in light of recent research.DISCUSSIONThere is growing concern about the over-diagnosis of bipolar disorder, and increasing evidence that bipolar depression may present differently to unipolar depression. Antipsychotics are the initial agents of choice for the acute treatment of mania. For preventive treatment, lithium and atypical antipsychotics have the strongest evidence base. Lithium has been shown to be more effective than valproate. The main effect of lithium and most of the atypical antipsychotics is on prevention of manic relapse; only olanzapine and quetiapine also protect against depression. Lamotrigine is an agent with evidence for prevention of depressive relapse, but have minimal activity against mania. The role of antidepressants remains contentious, while there is strong support for quetiapine. Finally, there is growing evidence from randomised controlled trials of the benefit of psychological therapies in conjunction with medications.
背景双相情感障碍影响约1%的澳大利亚人,严重影响人际关系、职业和一般功能能力。全科医生是双相情感障碍患者管理的核心。目的根据最近的研究,更新临床医生对双相情感障碍的认识、诊断和管理。讨论人们越来越担心双相情感障碍的过度诊断,越来越多的证据表明双相抑郁症可能与单极抑郁症表现不同。抗精神病药物是躁狂症急性治疗的首选药物。对于预防性治疗,锂和非典型抗精神病药物具有最强的证据基础。锂已被证明比丙戊酸钠更有效。锂和大多数非典型抗精神病药物的主要作用是预防躁狂复发;只有奥氮平和喹硫平可以预防抑郁症。拉莫三嗪是一种有证据表明可以预防抑郁复发的药物,但对躁狂的作用很小。抗抑郁药的作用仍然存在争议,而奎硫平有强有力的支持。最后,越来越多的证据来自随机对照试验,表明心理治疗与药物治疗相结合的益处。
{"title":"Bipolar disorder.","authors":"P. Mitchell","doi":"10.1353/book.49280","DOIUrl":"https://doi.org/10.1353/book.49280","url":null,"abstract":"BACKGROUND\u0000Bipolar disorder affects about 1% of Australians and impacts severely on relationships, careers and general functional capacity. General practitioners are central in the management of patients with bipolar disorder.\u0000\u0000\u0000OBJECTIVE\u0000To update clinicians on the recognition, diagnosis and management of bipolar disorder in light of recent research.\u0000\u0000\u0000DISCUSSION\u0000There is growing concern about the over-diagnosis of bipolar disorder, and increasing evidence that bipolar depression may present differently to unipolar depression. Antipsychotics are the initial agents of choice for the acute treatment of mania. For preventive treatment, lithium and atypical antipsychotics have the strongest evidence base. Lithium has been shown to be more effective than valproate. The main effect of lithium and most of the atypical antipsychotics is on prevention of manic relapse; only olanzapine and quetiapine also protect against depression. Lamotrigine is an agent with evidence for prevention of depressive relapse, but have minimal activity against mania. The role of antidepressants remains contentious, while there is strong support for quetiapine. Finally, there is growing evidence from randomised controlled trials of the benefit of psychological therapies in conjunction with medications.","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47571179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hoarse voice. 沙哑的声音。
Q3 Medicine Pub Date : 2021-12-15 DOI: 10.2307/j.ctv1c7zg62.18
P. Dhasmana
Various causes of hoarse voice are briefly discussed in this article. As it is not possible to give a detailed account of all the causes of this important condition affecting the larynx, any patient with persistent hoarseness of more than four weeks' duration should have his larynx thoroughly examined. The head mirror, suitable light source, laryngeal mirror, spirit lamp, pierce of gauze and a local anaethetical spray is all that is required to carry out a mirror examination of the larynx.
本文简要讨论了引起声音嘶哑的各种原因。由于无法详细说明这种影响喉部的重要疾病的所有原因,任何持续声音嘶哑超过四周的患者都应该彻底检查喉部。头镜、合适的光源、喉镜、灵灯、纱布穿孔和局部麻醉喷雾都是对喉部进行镜检所需的。
{"title":"Hoarse voice.","authors":"P. Dhasmana","doi":"10.2307/j.ctv1c7zg62.18","DOIUrl":"https://doi.org/10.2307/j.ctv1c7zg62.18","url":null,"abstract":"Various causes of hoarse voice are briefly discussed in this article. As it is not possible to give a detailed account of all the causes of this important condition affecting the larynx, any patient with persistent hoarseness of more than four weeks' duration should have his larynx thoroughly examined. The head mirror, suitable light source, laryngeal mirror, spirit lamp, pierce of gauze and a local anaethetical spray is all that is required to carry out a mirror examination of the larynx.","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44853670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Quality framework 质量框架
Q3 Medicine Pub Date : 2021-11-26 DOI: 10.18356/9789210000901c007
Purpose ......................................................................................................................................................... 1 Scope ............................................................................................................................................................ 1 Legislative Context ......................................................................................................................................... 1 Definitions ...................................................................................................................................................... 1 Policy Context ................................................................................................................................................ 3 University Governance Structure ............................................................................................................. 3 Policy Statement ............................................................................................................................................. 4 Quality Cycle Continuous Improvement .................................................................................................. 4 Responsibility ................................................................................................................................................. 5 Promulgation .................................................................................................................................................. 5 Implementation ............................................................................................................................................... 5
目的 .........................................................................................................................................................1范围 ............................................................................................................................................................1立法背景 .........................................................................................................................................1定义 ......................................................................................................................................................1政策背景下 ................................................................................................................................................3大学治理结构 .............................................................................................................3政策声明 .............................................................................................................................................4质量持续改进循环 ..................................................................................................4负责 .................................................................................................................................................5自发布之日起施行 ..................................................................................................................................................5实现 ...............................................................................................................................................5
{"title":"Quality framework","authors":"","doi":"10.18356/9789210000901c007","DOIUrl":"https://doi.org/10.18356/9789210000901c007","url":null,"abstract":"Purpose ......................................................................................................................................................... 1 Scope ............................................................................................................................................................ 1 Legislative Context ......................................................................................................................................... 1 Definitions ...................................................................................................................................................... 1 Policy Context ................................................................................................................................................ 3 University Governance Structure ............................................................................................................. 3 Policy Statement ............................................................................................................................................. 4 Quality Cycle Continuous Improvement .................................................................................................. 4 Responsibility ................................................................................................................................................. 5 Promulgation .................................................................................................................................................. 5 Implementation ............................................................................................................................................... 5","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67727004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Great expectations. 伟大的期望。
Q3 Medicine Pub Date : 2021-11-15 DOI: 10.2307/j.ctv20hcvdb.13
S. Devries
{"title":"Great expectations.","authors":"S. Devries","doi":"10.2307/j.ctv20hcvdb.13","DOIUrl":"https://doi.org/10.2307/j.ctv20hcvdb.13","url":null,"abstract":"","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46472245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexually Transmitted Infections: Adopting a Sexual Health Paradigm 性传播感染:采用性健康范式
Q3 Medicine Pub Date : 2021-03-24 DOI: 10.17226/25955
J. Crowley, A. Geller, S. Vermund
One in five people in the United States had a sexually transmitted infection (STI) on any given day in 2018, totaling nearly 68 million estimated infections. STIs are often asymptomatic (especially in women) and are therefore often undiagnosed and unreported. Untreated STIs can have severe health consequences, including chronic pelvic pain, infertility, miscarriage or newborn death, and increased risk of HIV infection, genital and oral cancers, neurological and rheumatological effects. In light of this, the Centers for Disease Control and Prevention, through the National Association of County and City Health Officials, commissioned the National Academies of Sciences, Engineering, and Medicine to convene a committee to examine the prevention and control of sexually transmitted infections in the United States and provide recommendations for action.In 1997, the Institute of Medicine released a report, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Although significant scientific advances have been made since that time, many of the problems and barriers described in that report persist today; STIs remain an underfunded and comparatively neglected field of public health practice and research. The committee reviewed the current state of STIs in the United States, and the resulting report, Sexually Transmitted Infections: Advancing a Sexual Health Paradigm, provides advice on future public health programs, policy, and research.
在2018年的任何一天,美国有五分之一的人患有性传播感染,估计感染总数接近6800万。性传播感染通常是无症状的(特别是在妇女中),因此往往未得到诊断和报告。未经治疗的性传播感染可造成严重的健康后果,包括慢性盆腔疼痛、不孕症、流产或新生儿死亡,并增加艾滋病毒感染、生殖器和口腔癌、神经和风湿病影响的风险。有鉴于此,疾病控制和预防中心通过全国县和市卫生官员协会,委托国家科学院、工程院和医学院召集一个委员会,审查美国性传播感染的预防和控制性传播感染,并提供行动建议。1997年,医学研究所发布了一份报告,《隐藏的流行病:直面性传播疾病》。尽管自那时以来取得了重大的科学进步,但该报告中描述的许多问题和障碍今天仍然存在;在公共卫生实践和研究中,性传播感染仍然是一个资金不足和相对被忽视的领域。该委员会审查了美国目前的性传播感染状况,并发表了题为《性传播感染:推进性健康范式》的报告,为未来的公共卫生项目、政策和研究提供了建议。
{"title":"Sexually Transmitted Infections: Adopting a Sexual Health Paradigm","authors":"J. Crowley, A. Geller, S. Vermund","doi":"10.17226/25955","DOIUrl":"https://doi.org/10.17226/25955","url":null,"abstract":"One in five people in the United States had a sexually transmitted infection (STI) on any given day in 2018, totaling nearly 68 million estimated infections. STIs are often asymptomatic (especially in women) and are therefore often undiagnosed and unreported. Untreated STIs can have severe health consequences, including chronic pelvic pain, infertility, miscarriage or newborn death, and increased risk of HIV infection, genital and oral cancers, neurological and rheumatological effects. In light of this, the Centers for Disease Control and Prevention, through the National Association of County and City Health Officials, commissioned the National Academies of Sciences, Engineering, and Medicine to convene a committee to examine the prevention and control of sexually transmitted infections in the United States and provide recommendations for action.In 1997, the Institute of Medicine released a report, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Although significant scientific advances have been made since that time, many of the problems and barriers described in that report persist today; STIs remain an underfunded and comparatively neglected field of public health practice and research. The committee reviewed the current state of STIs in the United States, and the resulting report, Sexually Transmitted Infections: Advancing a Sexual Health Paradigm, provides advice on future public health programs, policy, and research.","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67588620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Orofacial pain. Orofacial疼痛。
Q3 Medicine Pub Date : 2021-01-09 DOI: 10.1002/9781119328124.ch6
J. Gerschman, P. Reade
Pain or discomfort in the orofacial region usually has an organic and easily detectable cause. When an organic cause is absent or its magnitude is less than expected after the degree of concern expressed by the patient, a psychiatric factor must be considered. In such cases psychiatric treatment should be arranged to complement any necessary organic therapy.
口腔面部区域的疼痛或不适通常有一个有机的、易于检测的原因。当一个器质性原因不存在,或者在患者表达担忧程度后,其程度低于预期时,必须考虑精神因素。在这种情况下,应安排精神治疗,以补充任何必要的有机治疗。
{"title":"Orofacial pain.","authors":"J. Gerschman, P. Reade","doi":"10.1002/9781119328124.ch6","DOIUrl":"https://doi.org/10.1002/9781119328124.ch6","url":null,"abstract":"Pain or discomfort in the orofacial region usually has an organic and easily detectable cause. When an organic cause is absent or its magnitude is less than expected after the degree of concern expressed by the patient, a psychiatric factor must be considered. In such cases psychiatric treatment should be arranged to complement any necessary organic therapy.","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/9781119328124.ch6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42400650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pityriasis rosea.
Q3 Medicine Pub Date : 2020-10-01 DOI: 10.1891/9780826185235.0002p
R. Marks
{"title":"Pityriasis rosea.","authors":"R. Marks","doi":"10.1891/9780826185235.0002p","DOIUrl":"https://doi.org/10.1891/9780826185235.0002p","url":null,"abstract":"","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44512687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breastfeeding difficulties. 母乳喂养困难。
Q3 Medicine Pub Date : 2020-09-28 DOI: 10.1542/9781610024570-ch16
C. Lawlor-Smith, L. Lawlor-Smith
{"title":"Breastfeeding difficulties.","authors":"C. Lawlor-Smith, L. Lawlor-Smith","doi":"10.1542/9781610024570-ch16","DOIUrl":"https://doi.org/10.1542/9781610024570-ch16","url":null,"abstract":"","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47453268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Family matters. 家庭事务。
Q3 Medicine Pub Date : 2020-04-22 DOI: 10.2307/j.ctt183h03t.11
D. Lewis
There are many more 'family matters' issues worthy of reflection, but the examples represent some of the more common personal dilemmas facing medical practitioners, and in particular women doctors, based on both my own experience and conversations with colleagues. There are no simple or universally appropriate answers to any of the scenarios; I have not attempted to suggest solutions to any of the issues raised, but hope that some situations outlined will evoke empathy and promote thought, discussion or debate about ways that individual doctors could deal with such matters.
还有更多的“家庭问题”值得反思,但根据我自己的经验和与同事的交谈,这些例子代表了医疗从业者,特别是女医生面临的一些更常见的个人困境。对于任何一种情况,都没有简单或普遍适用的答案;我并没有试图对所提出的任何问题提出解决方案,但希望概述的一些情况能引起共鸣,并促进对个别医生处理此类问题的方式的思考、讨论或辩论。
{"title":"Family matters.","authors":"D. Lewis","doi":"10.2307/j.ctt183h03t.11","DOIUrl":"https://doi.org/10.2307/j.ctt183h03t.11","url":null,"abstract":"There are many more 'family matters' issues worthy of reflection, but the examples represent some of the more common personal dilemmas facing medical practitioners, and in particular women doctors, based on both my own experience and conversations with colleagues. There are no simple or universally appropriate answers to any of the scenarios; I have not attempted to suggest solutions to any of the issues raised, but hope that some situations outlined will evoke empathy and promote thought, discussion or debate about ways that individual doctors could deal with such matters.","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48768874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reactive Depression 反应性抑郁症
Q3 Medicine Pub Date : 2020-02-07 DOI: 10.32388/mee2uu
{"title":"Reactive Depression","authors":"","doi":"10.32388/mee2uu","DOIUrl":"https://doi.org/10.32388/mee2uu","url":null,"abstract":"","PeriodicalId":8653,"journal":{"name":"Australian family physician","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69636442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Australian family physician
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1